correct me if I am wrong but asx rules make companies estimate grades if they announce visual spodumene. After a few have overestimated and had their backs to the wall for overshooting, this has prevented many companies from announcing visual spodumene recently... This announcement is very encouraging, and shareholders should be excited for assays to come
